Article History
Accepted: 17 March 2022
First Online: 19 April 2022
Competing interests
: J.M. has served on advisory boards for Amgen, AstraZeneca, Audentes, Boston Biomedical, Bristol Myers Squibb, Cytokinetics, Deciphera, Immunocore, Ipsen, Janssen, Myovant, Precigen Triple-Gene, Regeneron and Takeda. R.A.d.B. reports research grants from Abbott, AstraZeneca, Boehringer Ingelheim, Cardior Pharmaceuticals, Ionis Pharmaceuticals, Novo Nordisk and Roche; and reports speaker fees from Abbott, AstraZeneca, Bayer, Novartis and Roche. A.K. declares no competing interests.